Wells Fargo Starts Amdocs Ltd. (DOX) at Outperform; Well Positioned as Leader in BSS/OSS Space
Get Alerts DOX Hot Sheet
Price: $61.40 +0.82%
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Wells Fargo initiates coverage on Amdocs Ltd. (NYSE: DOX) with an Outperform. PT range $36-$38.
Wells analyst says, "DOX is well positioned as a leader in the BSS/OSS space. DOX has relatively high revenue visibility with roughly 75-80% of revenue derived from long-term contracts. Carrier 4G deployments in the U.S. should support revenue growth and a migration to post paid and 3G adoption is driving strong growth in emerging markets. DOX has also become more shareholder-friendly over the last two years. We estimate that DOX will buy back just under 10% of its shares outstanding over the next year. Last, we think the company could issue a dividend in FY2013, which could attract more income-oriented investors."
For an analyst ratings summary and ratings history on Amdocs Ltd. click here. For more ratings news on Amdocs Ltd. click here.
Shares of Amdocs Ltd. closed at $30.54 yesterday.
Wells analyst says, "DOX is well positioned as a leader in the BSS/OSS space. DOX has relatively high revenue visibility with roughly 75-80% of revenue derived from long-term contracts. Carrier 4G deployments in the U.S. should support revenue growth and a migration to post paid and 3G adoption is driving strong growth in emerging markets. DOX has also become more shareholder-friendly over the last two years. We estimate that DOX will buy back just under 10% of its shares outstanding over the next year. Last, we think the company could issue a dividend in FY2013, which could attract more income-oriented investors."
For an analyst ratings summary and ratings history on Amdocs Ltd. click here. For more ratings news on Amdocs Ltd. click here.
Shares of Amdocs Ltd. closed at $30.54 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- Keefe, Bruyette & Woods Resumes Canadian Imperial Bank of Commerce (CM:CN) (CM) at Market Perform
- Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Dividend, Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share